Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249776 | SCV000306926 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000614222 | SCV000481627 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Laboratory for Molecular Medicine, |
RCV000249776 | SCV000540682 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Eurofins Ntd Llc |
RCV000249776 | SCV000705118 | benign | not specified | 2018-04-05 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000614222 | SCV001142011 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000614222 | SCV001156968 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2024-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000614222 | SCV001722806 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610609 | SCV001838440 | benign | not provided | 2018-08-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29248579, 19877056) |
Genome- |
RCV000614222 | SCV002513988 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002261025 | SCV002542679 | benign | Autoinflammatory syndrome | 2022-01-14 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000249776 | SCV004102348 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 34% of patients studied by a panel of primary immunodeficiencies. Number of patients: 33. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001610609 | SCV005278030 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000614222 | SCV000734739 | benign | X-linked lymphoproliferative disease due to XIAP deficiency | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001610609 | SCV001932687 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome |
RCV001610609 | SCV002074828 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |